Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

NCT00154141 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2006-07-13

No results posted yet for this study

Summary

A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.

Conditions

  • Peripheral Vascular Disease

Interventions

DRUG

Fibrin sealant (FS2)

Sponsors & Collaborators

  • OMRIX Biopharmaceuticals

    collaborator INDUSTRY
  • Ethicon, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-03-31

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00154141 on ClinicalTrials.gov